Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS.
iScience 26:107328 (2023)
Clonal hematopoiesis of indeterminate potential (CHIP) describes the age-related acquisition of somatic mutations in hematopoietic stem/progenitor cells (HSPC) leading to clonal blood cell expansion. Although CHIP mutations drive myeloid malignancies like myelodysplastic syndromes (MDS) it is unknown if clonal expansion is attributable to changes in cell type kinetics, or involves reorganization of the hematopoietic hierarchy. Using computational modeling we analyzed differentiation and proliferation kinetics of cultured hematopoietic stem cells (HSC) from 8 healthy individuals, 7 CHIP, and 10 MDS patients. While the standard hematopoietic hierarchy explained HSPC kinetics in healthy samples, 57% of CHIP and 70% of MDS samples were best described with alternative hierarchies. Deregulated kinetics were found at various HSPC compartments with high inter-individual heterogeneity in CHIP and MDS, while altered HSC rates were most relevant in MDS. Quantifying kinetic heterogeneity in detail, we show that reorganization of the HSPC compartment is already detectable in the premalignant CHIP state.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Computational Molecular Modelling ; Disease ; Experimental Systems For Structural Biology; Stem-cells; Myelodysplastic Syndromes; Progenitor; Risk; Differentiation; Hierarchy; Landscape
ISSN (print) / ISBN
2589-0042
e-ISSN
2589-0042
Journal
iScience
Quellenangaben
Volume: 26,
Issue: 8,
Article Number: 107328
Publisher
Elsevier
Publishing Place
Amsterdam ; Bosten ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Computational Biology (ICB)
Institute of AI for Health (AIH)
Institute of AI for Health (AIH)
Grants
Marie Curie Actions (MSCA)
Joachim Herz Stiftung
ERC under the European Union
BMBF
European Research Council (ERC) under the European Union
German Cancer Consortium joint funding program (DKTK CHOICE)
Deutsche Jose Carreras Leukamie Stiftung (DJCLS)
Deutsche Forschungsgemeinschaft
Joachim Herz Stiftung
ERC under the European Union
BMBF
European Research Council (ERC) under the European Union
German Cancer Consortium joint funding program (DKTK CHOICE)
Deutsche Jose Carreras Leukamie Stiftung (DJCLS)
Deutsche Forschungsgemeinschaft